Literature DB >> 31145555

Cerebral Open Flow Microperfusion to Monitor Drug Transport Across the Blood-Brain Barrier.

Joanna Hummer1, Thomas Altendorfer-Kroath1, Thomas Birngruber1.   

Abstract

Drugs for neurological diseases have to cross the blood-brain barrier (BBB) to induce their therapeutic effect. In vivo drug quantification in the brain is challenging, because invasive methods damage the BBB and measurement results may be confounded by drug leakage from the blood into the brain through the disrupted BBB. Cerebral open flow microperfusion (cOFM) is an in vivo sampling technique that allows BBB healing and re-establishment after probe implantation and before sampling is performed. It therefore provides the opportunity to sample compounds in cerebral interstitial fluid with an intact BBB. This article comprehensively describes the experimental setup and procedures, perfusate requirements, critical parameters, common problems that may occur, and their causes and solutions. Typical results from a cOFM sampling experiment are presented and discussed. This protocol provides a tool for performing pharmacokinetic and pharmacodynamic studies in mouse or rat brain with an intact BBB.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  BBB; blood-brain barrier; cOFM; cerebral PD; cerebral PK; cerebral interstitial fluid; cerebral open flow microperfusion; permeation

Mesh:

Substances:

Year:  2019        PMID: 31145555     DOI: 10.1002/cpph.60

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  3 in total

Review 1.  Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid.

Authors:  Marie-Laure Custers; Liam Nestor; Dimitri De Bundel; Ann Van Eeckhaut; Ilse Smolders
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

2.  Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment.

Authors:  Yang Hu; Margareta Hammarlund-Udenaes
Journal:  Mol Pharm       Date:  2020-10-16       Impact factor: 4.939

3.  Innovative Platform for the Advanced Online Monitoring of Three-Dimensional Cells and Tissue Cultures.

Authors:  Sebastian Kreß; Roland Schaller-Ammann; Jürgen Feiel; Joachim Wegener; Joachim Priedl; Wolf Dietrich; Cornelia Kasper; Dominik Egger
Journal:  Cells       Date:  2022-01-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.